Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 27

    1.

    Clinical pharmacokinetics of nateglinide: a rapidly-absorbed, short-acting insulinotropic agent.

    McLeod JF.

    Clin Pharmacokinet. 2004;43(2):97-120. Review.PMID: 14748619 [PubMed - indexed for MEDLINE]Related articles

    2.

    "Cocktail" approaches and strategies in drug development: valuable tool or flawed science?

    Zhou H, Tong Z, McLeod JF.

    J Clin Pharmacol. 2004 Feb;44(2):120-34. Review.PMID: 14747420 [PubMed - indexed for MEDLINE]Related articles

    3.

    Tegaserod pharmacokinetics are similar in patients with severe renal insufficiency and in healthy subjects.

    Swan SK, Zhou H, Horowitz A, Alladina L, Hubert M, Appel-Dingemanse S, Osborne S, Lambrecht L, McLeod JF.

    J Clin Pharmacol. 2003 Apr;43(4):359-64.PMID: 12723456 [PubMed - indexed for MEDLINE]Related articles

    4.

    Pharmacokinetics of nateglinide in renally impaired diabetic patients.

    Devineni D, Walter YH, Smith HT, Lee JS, Prasad P, McLeod JF.

    J Clin Pharmacol. 2003 Feb;43(2):163-70.PMID: 12616669 [PubMed - indexed for MEDLINE]Related articles

    5.

    Importance of early phase insulin secretion to intravenous glucose tolerance in subjects with type 2 diabetes mellitus.

    Kahn SE, Montgomery B, Howell W, Ligueros-Saylan M, Hsu CH, Devineni D, McLeod JF, Horowitz A, Foley JE.

    J Clin Endocrinol Metab. 2001 Dec;86(12):5824-9.PMID: 11739446 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    The effects of tegaserod (HTF 919) on the pharmacokinetics and pharmacodynamics of digoxin in healthy subjects.

    Zhou H, Horowitz A, Ledford PC, Hubert M, Appel-Dingemanse S, Osborne S, McLeod JF.

    J Clin Pharmacol. 2001 Oct;41(10):1131-9.PMID: 11583482 [PubMed - indexed for MEDLINE]Related articles

    7.

    The effect of food on the oral bioavailability and the pharmacodynamic actions of the insulinotropic agent nateglinide in healthy subjects.

    Karara AH, Dunning BE, McLeod JF.

    J Clin Pharmacol. 1999 Feb;39(2):172-9.PMID: 11563410 [PubMed - indexed for MEDLINE]Related articles

    8.

    Tegaserod coadministration does not alter the pharmacokinetics of theophylline in healthy subjects.

    Zhou H, Khalilieh S, Svendsen K, Pommier F, Osborne S, Appel-Dingemanse S, Lasseter K, McLeod JF.

    J Clin Pharmacol. 2001 Sep;41(9):987-93.PMID: 11549104 [PubMed - indexed for MEDLINE]Related articles

    9.

    Pharmacokinetics and metabolism of nateglinide in humans.

    Weaver ML, Orwig BA, Rodriguez LC, Graham ED, Chin JA, Shapiro MJ, McLeod JF, Mangold JB.

    Drug Metab Dispos. 2001 Apr;29(4 Pt 1):415-21.PMID: 11259325 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Mealtime glucose regulation with nateglinide in healthy volunteers: comparison with repaglinide and placebo.

    Kalbag JB, Walter YH, Nedelman JR, McLeod JF.

    Diabetes Care. 2001 Jan;24(1):73-7.PMID: 11194245 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Population PK and PK/PD modelling of microencapsulated octreotide acetate in healthy subjects.

    Zhou H, Chen TL, Marino M, Lau H, Miller T, Kalafsky G, McLeod JF.

    Br J Clin Pharmacol. 2000 Dec;50(6):543-52.PMID: 11136293 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Mealtime glucose regulation by nateglinide in type-2 diabetes mellitus.

    Walter YH, Spratt DI, Garreffa S, McLeod JF.

    Eur J Clin Pharmacol. 2000 May;56(2):129-33.PMID: 10877006 [PubMed - indexed for MEDLINE]Related articles

    13.

    Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin.

    Hirschberg Y, Karara AH, Pietri AO, McLeod JF.

    Diabetes Care. 2000 Mar;23(3):349-53.PMID: 10868864 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Single-dose pharmacokinetics of nateglinide in subjects with hepatic cirrhosis.

    Choudhury S, Hirschberg Y, Filipek R, Lasseter K, McLeod JF.

    J Clin Pharmacol. 2000 Jun;40(6):634-40.PMID: 10868314 [PubMed - indexed for MEDLINE]Related articles

    15.

    Pharmacokinetics, pharmacodynamics, and safety of microencapsulated octreotide acetate in healthy subjects.

    Chen T, Miller TF, Prasad P, Lee J, Krauss J, Miscik K, Kalafsky G, McLeod JF.

    J Clin Pharmacol. 2000 May;40(5):475-81.PMID: 10806600 [PubMed - indexed for MEDLINE]Related articles

    16.

    Synergistic effects of nateglinide and meal administration on insulin secretion in patients with type 2 diabetes mellitus.

    Keilson L, Mather S, Walter YH, Subramanian S, McLeod JF.

    J Clin Endocrinol Metab. 2000 Mar;85(3):1081-6.PMID: 10720043 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effect of meal timing not critical for the pharmacokinetics of tegaserod (HTF 919).

    Zhou H, Khalilieh S, Lau H, Guerret M, Osborne S, Alladina L, Laurent AL, McLeod JF.

    J Clin Pharmacol. 1999 Sep;39(9):911-9.PMID: 10471981 [PubMed - indexed for MEDLINE]Related articles

    18.

    Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues.

    Mercado M, DáVila N, McLeod JF, Baumann G.

    J Clin Endocrinol Metab. 1994 Mar;78(3):731-5.PMID: 8126150 [PubMed - indexed for MEDLINE]Related articles

    19.

    Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation.

    McLeod JF, Kovács L, Gaskill MB, Rittig S, Bradley GS, Robertson GL.

    J Clin Endocrinol Metab. 1993 Sep;77(3):599A-599G.PMID: 8370682 [PubMed - indexed for MEDLINE]Related articles

    20.

    Osteoporosis, cytokines, and glucocorticoids.

    McLeod JF.

    Allergy Proc. 1993 Sep-Oct;14(5):363-4. No abstract available. PMID: 8288119 [PubMed - indexed for MEDLINE]Related articles

    21.

    Vitamin D binding protein: genomic structure, functional domains, and mRNA expression in tissues.

    Cooke NE, McLeod JF, Wang XK, Ray K.

    J Steroid Biochem Mol Biol. 1991;40(4-6):787-93. Review.PMID: 1958576 [PubMed - indexed for MEDLINE]Related articles

    22.

    The vitamin D-binding protein, alpha-fetoprotein, albumin multigene family: detection of transcripts in multiple tissues.

    McLeod JF, Cooke NE.

    J Biol Chem. 1989 Dec 25;264(36):21760-9.PMID: 2480956 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Vitamin D-binding protein. Structure and pattern of expression.

    Cooke NE, Murgia A, McLeod JF.

    Ann N Y Acad Sci. 1988;538:49-59. No abstract available. PMID: 3190085 [PubMed - indexed for MEDLINE]Related articles

    24.

    Vitamin D binding protein sequesters monomeric actin in the circulation of the rat.

    Harper KD, McLeod JF, Kowalski MA, Haddad JG.

    J Clin Invest. 1987 May;79(5):1365-70. Erratum in: J Clin Invest 1987 Jul;80(1):277. PMID: 3571491 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Detection of vitamin D binding protein on the surface of cytotrophoblasts isolated from human placentae.

    Nestler JE, McLeod JF, Kowalski MA, Strauss JF 3rd, Haddad JG Jr.

    Endocrinology. 1987 May;120(5):1996-2002.PMID: 3552627 [PubMed - indexed for MEDLINE]Related articles

    27.

    Comparison of inhibition of bone resorption and escape with calcitonin and dibutyryl 3',5' cyclic adenosine monophosphate.

    McLeod JF, Raisz LG.

    Endocr Res Commun. 1981;8(1):49-59.PMID: 6263578 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...